TIAA Trust, National Association’s Novo Nordisk NVO Stock Holding History

TIAA Trust, National Association’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.4K	Sell	343 -8,392	-96%	-$361K	﹤0.01%	306
2026 Q1	$321K	Buy	8,735 +444	+5%	+$21K	0.02%	206
2025 Q4	$422K	Sell	8,291 -2,850	-26%	-$146K	﹤0.01%	509
2025 Q3	$618K	Sell	11,141 -216,234	-95%	-$12.7M	﹤0.01%	452
2025 Q2	$15.7M	Buy	227,375 +215,928	+1,886%	+$14.7M	0.04%	158
2025 Q1	$795K	Sell	11,447 -2,236	-16%	-$185K	﹤0.01%	395
2024 Q4	$1.18M	Buy	13,683 +51	+0.4%	+$5.51K	﹤0.01%	342
2024 Q3	$1.62M	Buy	13,632 +903	+7%	+$120K	﹤0.01%	312
2024 Q2	$1.82M	Buy	12,729 +1,400	+12%	+$186K	0.01%	286
2024 Q1	$1.45M	Buy	11,329 +1,745	+18%	+$208K	﹤0.01%	306
2023 Q4	$991K	Buy	9,584 +468	+5%	+$46.3K	﹤0.01%	331
2023 Q3	$829K	Buy	+9,116	New	+$803K	﹤0.01%	351

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

TIAA Trust, National Association's NVO Position: Q2 2026 in Review

TIAA Trust, National Association reduced its Novo Nordisk (NVO) stake by 96% in Q2 2026, selling an estimated $361K and leaving 343 shares worth $16.4K. The position accounts for ﹤0.01% of the portfolio, ranked #306.

TIAA Trust, National Association first reported a position in NVO in Q3 2023 and has held it in 12 quarters since. The position peaked at $15.7M in Q2 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

TIAA Trust, National Association held 343 shares of Novo Nordisk worth $16.4K as of Q2 2026.
TIAA Trust, National Association sold 8,392 Novo Nordisk shares in Q2 2026, an estimated $361K.
Novo Nordisk made up ﹤0.01% of TIAA Trust, National Association's portfolio in Q2 2026, its #306 holding.
TIAA Trust, National Association first reported a position in Novo Nordisk in Q3 2023 and has held it in 12 quarters since.
TIAA Trust, National Association's Novo Nordisk position peaked at $15.7M in Q2 2025.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on TIAA Trust, National Association's 13F filing for Q2 2026, filed 10 Aug 2026.